首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于网络药理学和分子对接技术探究青蒿素对多囊卵巢综合征的潜在治疗机制
引用本文:余伟莉,韦伊芳,叶姿劭,刘爱芬,王成牛,张磊.基于网络药理学和分子对接技术探究青蒿素对多囊卵巢综合征的潜在治疗机制[J].药学实践杂志,2023,41(12):714-721.
作者姓名:余伟莉  韦伊芳  叶姿劭  刘爱芬  王成牛  张磊
作者单位:南通大学医学院交叉医学研究所, 江苏 南通 226001;海军特色医学中心, 上海 200052;南通大学医学院交叉医学研究所, 江苏 南通 226001;南通大学公共卫生学院营养与食品卫生系, 江苏 南通 226019;南通大学医学院交叉医学研究所, 江苏 南通 226001;海军军医大学药学系, 上海 200433
基金项目:国家自然科学基金资助项目(81901442,82001606)
摘    要:目的 应用网络药理学和分子对接技术探索青蒿素对多囊卵巢综合征(polycystic ovary syndrome,PCOS)的潜在作用机制。方法 通过Pubchem、Swiss Target Prediction、PharmMapper数据库预测青蒿素作用靶点,利用GeneCard、DisGeNET数据库获取与PCOS有关靶点;应用韦恩图分析青蒿素与PCOS的交集靶点;利用String软件对交集靶点进行PPI蛋白网络互作分析,并利用Cytoscape软件进行核心靶点筛选;应用DAVID数据库进行基因本体(gene ontology,GO)功能、京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)富集分析,并借助在线软件对分析结果进行可视化;通过Chemdraw、PyMol、Auto Dock Tools软件及RCSB PDB数据库对青蒿素及核心靶蛋白进行分子对接。结果 得到青蒿素靶点229个,PCOS靶点1 292个,韦恩图分析交集靶点90个,潜在核心靶点5个,分别为丝氨酸/苏氨酸蛋白激酶(serine/threonine...

关 键 词:青蒿素  多囊卵巢综合征  网络药理学  分子对接
收稿时间:2022/9/20 0:00:00
修稿时间:2023/5/20 0:00:00

Exploration on the potential therapeutic mechanism of artemisinin in polycystic ovary syndrome based on network pharmacology and molecular docking technology
YU Weili,WEI Yifang,YE Zishao,LIU Aifen,WANG Chengniu,ZHANG Lei.Exploration on the potential therapeutic mechanism of artemisinin in polycystic ovary syndrome based on network pharmacology and molecular docking technology[J].The Journal of Pharmaceutical Practice,2023,41(12):714-721.
Authors:YU Weili  WEI Yifang  YE Zishao  LIU Aifen  WANG Chengniu  ZHANG Lei
Institution:Institute of Interdisciplinary Integrative Medicine Research, School of Medicine, Nantong University, Nantong 226001, China;Naval Medical Center, Naval Medical University, Shanghai 200052, China;Institute of Interdisciplinary Integrative Medicine Research, School of Medicine, Nantong University, Nantong 226001, China;Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong 226019, China; Institute of Interdisciplinary Integrative Medicine Research, School of Medicine, Nantong University, Nantong 226001, China;School of Pharmacy, Naval Medical University, Shanghai 200433, China
Abstract:Objective To explore the potential mechanism of artemisinin in the treatment of polycystic ovary syndrome (PCOS) by network pharmacology and molecular docking technology. Methods The corresponding targets of natural product artemisinin were obtained from PubChem, Swiss Target Prediction and PharmMapper databases, targets related to PCOS were obtained through GeneCards and DisGeNET databases; the intersection target genes of Artemisinin and PCOS were screened by Draw Venn diagram. Then the protein-protein interaction network (PPI) was constructed according to the intersection target genes through the STRING Database, and the core targets were screened by Cytoscape. Besides, gene ontology (GO) function and Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis was performed by DAVID Database, and finally the data were analyzed visually by the online platform. Molecular docking of artemisinin and core targets were performed by Chemdraw, Pymol, Auto Dock Tools and RCSB PDB database. Results A total of 229 targets of artemisinin and 1292 targets of PCOS were screened out, 90 overlapping targets were obtained by Draw Venn diagram, and 5 potential core targets, AKT1, ESR1, MMP9, PPARG, MMP2, were mainly act on PI3K Akt, MAPK, RAS, endocrine resistance and other signal pathways. Molecular docking results showed that there were molecular binding sites between artemisinin and core targets. Conclusion It is preliminarily analyzed that artemisinin may play a therapeutic role in PCOS through multiple targets and mechanisms.
Keywords:artemisinin  polycystic ovary syndrome  network pharmacology  molecular docking
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号